Secreted Phosphoprotein-1 Mediates Muscle Resident Schwann Cell Dynamics and NMJ Regeneration Post Nerve Injury
Authors: Guzman Steve , Abu-Mahfouz Ahmad , Davis Carol , Ruiz Lloyd , Macpherson Peter , Brooks Susan 
Published: May 2024

The maintenance of neuromuscular junctions (NMJs) is crucial for combating degenerative neuromuscular diseases. Maintenance of the NMJ involves turnover and regeneration with these processes dependant on the activation of Schwann cells by specific molecular cues within the muscular environment. Secreted phosphoprotein-1 (SPP1), known as osteopontin, is a chemokine that is rapidly upregulated following nerve injury. Its precise influence on Schwann cell-mediated nerve regeneration, however, remains to be elucidated. Our recent single-cell RNA sequencing data has uncovered a previously unrecognized interaction between myelinating Schwann cells and terminal Schwann cells (tSCs), mediated by SPP1 signaling. We propose that this interaction, orchestrated by SPP1, is crucial for tSC proliferation and ultimately, successful reinnervation of muscle fibers post-injury. To investigate the effect of nerve injury on SPP1 signaling gene expression within skeletal muscle, we conducted sciatic nerve crush experiments in two-month-old C57BL/6 mice. We compared gene expression profiles associated with denervation and SPP1 signaling in the gastrocnemius muscles of uninjured controls to those at 7, 14, and 28 days post-injury (DPI). We found significant transient increases in Spp1 and its receptor genes Cd44 and Itgav, peaking at 7 DPI and returning to baseline by 14 DPI. To further elucidate the role of SPP1 in muscle reinnervation and its impact on tSC responses following nerve injury, we conducted peroneal nerve injuries in S100-GFP transgenic mice and administered either an SPP1 neutralizing antibody (Spp1-nAb) or a saline solution intramuscularly. Direct muscle stimulation force testing revealed comparable evoked forces between both groups, however nerve-evoked muscle forces were significantly diminished by 43% in the Spp1-nAb-treated mice. The Spp1-nAb treated mice also demonstrated a 38% reduction in nerve-to-muscle force ratios compared to the saline group. Histological assessments post-injury showed that mice given Spp1-nAb at 7 DPI had markedly reduced nerve terminal and synaptic areas compared to saline-treated controls. Similarly, a greater percentage of muscle fibers remained denervated with Spp1-nAb treatment (67% vs 33% in saline), accompanied by a reduction in NMJ synaptic area. An analysis of tSCs further indicated a decreased count per NMJ and a reduction in overall tSC area upon SPP1 signaling inhibition. Our comprehensive analysis establishes the essential function of Spp1 in muscle reinnervation, as evidenced by its role in enhancing tSC numbers at the NMJ. These findings provide significant contributions to our understanding of the molecular mechanisms essential for NMJ repair and maintenance, with a particular focus on the role of tSCs in this process.

This work was supported by the National institutes of Health (NIH) under the awards R01(AG050676) (SVB), P01 (AG051442) (SVB), P30 (AR069620)(SVB), T32 (AG000114)(SDG), and the American Physiological Society Porter Fellowship (SDG).

This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.